marking new milestones with immunotherapy in locally advanced and early lung cancer
Published 3 years ago • 287 plays • Length 59:37Download video MP4
Download video MP3
Similar videos
-
59:24
marking new milestones with immunotherapy in locally advanced and early lung cancer
-
1:06:23
immunotherapy in lung cancer: rationale, evidence, and implications for the multidisciplinary team
-
1:10:25
how to select the right immunotherapy for first-line treatment of advanced nsclc
-
1:03:31
elevating care in resectable stage i-iii nsclc
-
1:11:21
maximizing the potential of immunotherapy in unresectable stage iii nsclc
-
1:25:42
navigating immunotherapies and combinations in the search for the best strategy for each patient
-
59:58
management of esophageal/gej cancers: an interdisciplinary tumor board on adjuvant immunotherapy
-
58:30
the potential of her2-, her3-, and trop2-targeted therapies to address unmet needs in advanced nsclc
-
26:13
immunotherapies in lung cancer | 2022 evolution conference
-
1:12:08
watch dr. baugh & awad, discuss the latest cancer immunotherapy from #acep21: https://bit.ly/3ptzhzh
-
55:12
selecting and sequencing targeted and immunotherapy regimens for patients with rcc
-
1:04:00
watch drs. jones and pennell discuss the latest in egfr updates - https://bit.ly/egfr_2021
-
4:06
cancer treatment: major milestones & what's next in the 2020s
-
1:15
using multimodal artificial intelligence models in the stampede trials
-
10:20
imaging 101: immunotherapy criteria
-
0:52
maximizing cancer care: enhancing treatment with immune-boosting therapies
-
1:23
diagnosing and treating lung cancer
-
40:54
lung cancer at the advent of targeted therapy - milestones in oncology
-
0:32
individualized immunotherapy